Citigroup’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-7,600
| Closed | -$906K | – | 6496 |
|
|
2020
Q4 | $906K | Sell |
7,600
-130,700
| -95% | -$15.9M | ﹤0.01% | 3630 |
|
|
2020
Q3 | $15.8M | Buy |
138,300
+124,800
| +924% | +$14.7M | 0.01% | 1043 |
|
|
2020
Q2 | $1.54M | Sell |
13,500
-43,700
| -76% | -$4.64M | ﹤0.01% | 3116 |
|
|
2020
Q1 | $4.59M | Buy |
57,200
+9,200
| +19% | +$952K | ﹤0.01% | 1749 |
|
|
2019
Q4 | $5.13M | Buy |
48,000
+800
| +2% | +$83.4K | ﹤0.01% | 2008 |
|
|
2019
Q3 | $5.05M | Buy |
47,200
+12,800
| +37% | +$1.31M | ﹤0.01% | 1932 |
|
|
2019
Q2 | $3.5M | Sell |
34,400
-13,400
| -28% | -$1.29M | ﹤0.01% | 2267 |
|
|
2019
Q1 | $4.3M | Buy |
47,800
+27,500
| +135% | +$2.38M | ﹤0.01% | 1930 |
|
|
2018
Q4 | $1.69M | Sell |
20,300
-41,100
| -67% | -$3.85M | ﹤0.01% | 2834 |
|
|
2018
Q3 | $6.63M | Buy |
61,400
+43,400
| +241% | +$4.76M | 0.01% | 1592 |
|
|
2018
Q2 | $1.98M | Sell |
18,000
-10,500
| -37% | -$1.09M | ﹤0.01% | 2687 |
|
|
2018
Q1 | $2.86M | Buy |
28,500
+8,300
| +41% | +$850K | ﹤0.01% | 2291 |
|
|
2017
Q4 | $1.99M | Buy |
20,200
+5,000
| +33% | +$474K | ﹤0.01% | 2678 |
|
|
2017
Q3 | $1.42M | Buy |
15,200
+12,000
| +375% | +$1.27M | ﹤0.01% | 3016 |
|
|
2017
Q2 | $356K | Buy |
3,200
+800
| +33% | +$84.6K | ﹤0.01% | 4302 |
|
|
2017
Q1 | $236K | Sell |
2,400
-25,800
| -91% | -$2.46M | ﹤0.01% | 4520 |
|
|
2016
Q4 | $2.59M | Buy |
28,200
+3,600
| +15% | +$310K | ﹤0.01% | 2624 |
|
|
2016
Q3 | $2.08M | Buy |
24,600
+2,400
| +11% | +$202K | ﹤0.01% | 2473 |
|
|
2016
Q2 | $1.81M | Sell |
22,200
-15,800
| -42% | -$1.2M | ﹤0.01% | 2413 |
|
|
2016
Q1 | $2.71M | Sell |
38,000
-1,800
| -5% | -$121K | ﹤0.01% | 2157 |
|
|
2015
Q4 | $2.83M | Buy |
39,800
+13,400
| +51% | +$901K | ﹤0.01% | 2213 |
|
|
2015
Q3 | $1.62M | Sell |
26,400
-6,700
| -20% | -$468K | ﹤0.01% | 2647 |
|
|
2015
Q2 | $2.4M | Buy |
33,100
+13,300
| +67% | +$982K | ﹤0.01% | 2354 |
|
|
2015
Q1 | $1.52M | Sell |
19,800
-22,200
| -53% | -$1.59M | ﹤0.01% | 2714 |
|
|
2014
Q4 | $2.82M | Sell |
42,000
-4,300
| -9% | -$271K | ﹤0.01% | 2217 |
|
|
2014
Q3 | $2.81M | Buy |
46,300
+34,400
| +289% | +$2.12M | ﹤0.01% | 2292 |
|
|
2014
Q2 | $698K | Sell |
11,900
-186,000
| -94% | -$10.9M | ﹤0.01% | 3236 |
|
|
2014
Q1 | $11.5M | Buy |
197,900
+27,300
| +16% | +$1.46M | 0.01% | 1059 |
|
|
2013
Q4 | $9.13M | Buy |
170,600
+143,700
| +534% | +$8.52M | 0.01% | 1326 |
|
|
2013
Q3 | $1.66M | Sell |
26,900
-94,800
| -78% | -$5.67M | ﹤0.01% | 2569 |
|
|
2013
Q2 | $7.38M | Buy |
+121,700
| New | +$7.25M | 0.01% | 1314 |
|
Other funds holding DGX
VCM
VPM
EIG
Citigroup's DGX Position: Q1 2026 in Review
Citigroup reduced its Quest Diagnostics (DGX) stake by 7.3% in Q1 2026, selling an estimated $4.41M and leaving 287,123 shares worth $56.3M. The position accounts for 0.02% of the portfolio, ranked #595.
Citigroup first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $60.9M in Q3 2025. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- Citigroup held 287,123 shares of Quest Diagnostics worth $56.3M as of Q1 2026.
- Citigroup sold 22,694 Quest Diagnostics shares in Q1 2026, an estimated $4.41M.
- Quest Diagnostics made up 0.02% of Citigroup's portfolio in Q1 2026, its #595 holding.
- Citigroup first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
- Citigroup's Quest Diagnostics position peaked at $60.9M in Q3 2025.
- 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.